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Abstract 
The effect of the aqueous extracts of Catharanthus roseus and chlorpropamide (Diabenese) on 
the levels of serum cholesterol, total protein, lipid peroxidation, blood glucose and liver enzymes 
were compared in alloxan-induced diabetic rats. Four groups namely A, B, C and D comprising 
of nine rats each were used. A and B were administered with chlorpropamide and C. roseus 
extracts respectively, while C and D served as diabetic and non-diabetic controls respectively. 
The results showed comparatively significant reductions (P0.05) in the levels of glucose, 
protein, cholesterol, lipid peroxidation and liver enzymes in the groups administered C. roseus 
extracts and chlorpropamide relative to the controls. The reductions were higher in the groups 
treated with C. roseus extract than in the groups treated with diabenese. 
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INTRODUCTION 
 
Diabetes is not a single disease but a syndrome 
that is characterized by a total  or relative lack of 
insulin leading to persistent elevation of blood 
glucose as well as alteration in lipid and protein 
metabolism1.This syndrome can occur as a result 
of some secondary causes such as 
pancreatectomy and iron overload  of  beta-cells 
resulting from haemachromatosis. Other causes 
include excess cortisol production in Cushing’s 
syndrome and excess growth hormone secretion 
in acromegaly and insulin-resistant 
syndrome2.Two basic types of diabetes are 
common namely type 1 or insulin-dependent and 
type 2 or non-insulin-dependent diabetes3. Type 
1 commonly seen in juveniles is characterized 
by failure to produce insulin due to autoimmune 
destruction of beta-cells of the pancreas while 
type 2 is usually adult-onset and is associated 
with insufficient production of insulin and loss 
of responsiveness by cells to insulin4,5. Insulin is 
pivotal to carbohydrate metabolism and controls 
the concentration of glucose in the blood via a 
feedback mechanism. 
 
Diabetes is characterized by symptoms such as 
weakness, polyuria, excessive thirst as well as 
ketonemia, ketouria and ketosis due to altered 
metabolism of lipids and proteins. It is 
associated with abnormalities such as kidney 
failure, nervous defect, impotence, blindness, 
stroke and heart diseases. Abnormalities in lipid 
metabolism may contribute to excessive hepatic 
glucose through gluconeogenesis as well as 
abnormal drive from the autonomic nervous 
system. 
 
Diabetes especially type 2 is difficult to treat and 
will continuously get worse with time. The 
supplemental use of insulin in controlling blood 
sugar is complex and involves accurate and 
timed injection of the hormone as food is 
ingested and digested and usually leads to 
treatment failures. Commonly used oral 
antiglycemic drugs used in the treatment of 
diabetes include the older sulfonylurea which act 
by stimulating production of insulin and the 
newer ones that act by increasing sensitivity of 
cells to insulin and prevents additional release of 
glucose by the liver and intestines. 
Chlorpropamide (1-{p-chlorophenyl-sulfonyl-3-
propylurea, MW; 276.74) commercially sold as 
Diabenese is a sulfonamide derivative that 
occurs as a white crystalline solid insoluble in 
water but soluble in alcohol. It is rapidly 
absorbed and metabolized and excreted 
unchanged with a half life of 36 hours6. Its 
metabolism contributes to its high antidiabetic 
activity and minimal side effects compared to 
other antidiabetic drugs. However its 
pronounced accumulation due to its long 
elimination period could be a serious problem. 
The sulfonylurea moiety is responsible for its 
distribution and binding to beta-cell surface and 
insulin producing actions7. 
 
Treatment failure and side effects associated 
with oral hypoglycemic drugs have led to 
alternative forms of treatment and management 
of diabetes. Plants such as Catharanthus roseus, 
Azadiracta indica, Ficus racemosa, Trignonella 
foenum etc are now used in alternative therapy 
for diabetes as a result of their large content of 
bioactive substances such as glycosides, sterols, 
flavonoids, alkaloids, tannins, etc8-10. C.roseus, 
formerly known as Vinca rosea is the common 
or Madagascar periwinkle. It is a perennial 
evergreen herb of the family Apocynaceae 
originally native to Madagascar11,12. It grows to 
a height of two feet and has dark green glossy 
leaves and pale pink or white flowers. The 
organic extracts of C. roseus is used in the 
folklore treatment of diabetes, malaria, leukemia 
wasp stings, sore throat, eye irritation, infections 
and to stop bleeding13. It is also used a as an 
astringent, diuretic and expectorant. The plant 
contains about seventy alkaloids some of which 
include cartharathine, lochnenine, vindoline 
vindolinenine, vincristine, vinblastine, vindoline, 
tetrahydroalstronine, reserpinne, serpentine, 
etc14. 
 
Diabetes is assuming an increasing epidemic 
trend affecting about 10% of the world’s 
population15. The consequent death and 
economic cost associated with diabetes is 
enormous and its treatment needs to be reviewed 
and improved. There is perceived failure of 
treating diabetes using drugs and emphasis is 
gradually shifting to use of plant products, diet 
management and exercise16,17. The objective of 
this study is geared in this direction by 
comparing the antidiabetic effects of 
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chlorpropamide and aqueous extracts of C. 
roseus instead of the organic extracts on alloxan-
induced diabetic rats. The results will further 
substantiate or deny claims of the use of plants 
as better alternative therapies to drugs in the 
treatment and management of diabetes. 
 
MATERIALS AND METHODS 
 
Plant 
The plant used in this study was collected from 
the stand at the courtyard around the Dean’s 
office, Faculty of Biological and Physical 
Sciences, Abia State University, Uturu, Nigeria. 
The specimens were authenticated by Dr. C. U 
Okeke, a botanist in the Department of Botany, 
Abia State University, Uturu, Nigeria. 
 
Laboratory animals 
A total of thirty six apparently healthy, male 
albino rats of about eight weeks old and 
weighing between130 ±30.5grams were 
purchased from the animal house of the Faculty 
of Pharmaceutical Sciences, University of 
Nigeria, Nsukka, Nigeria. The Animals were 
housed in clean metallic cages and kept in a well 
ventilated room. Their cages were cleaned every 
two days.  
  
Preparation of plant extract   
200g of the fresh, dried leaves, flowers and 
tender stems of C. roseus were ground using a 
Gallenkamp electric blender. The sample was 
soaked in 200mls of distilled water for 12hours 
and thereafter filtered with a cheese cloth. The 
filtrate was concentrated using a rotary 
evaporator to obtain 20g powdered extract. 
 
Animal grouping and treatment 
Thirty six albino rats were randomly assigned 
into four groups namely A, B, C, and D 
comprising of nine animals each. Animals in A, 
B and C were each given single doses of 
70mg/ml of alloxan intraperitonealy to induce 
diabetes. Animals in group D were not injected 
with alloxan and served as non-diabetic control. 
Diabetes induction was confirmed by increased 
blood glucose in excess of 300mg/ml which 
occurred after four days of alloxan 
administration. Twenty four hours following the 
induction of diabetes, treatment with the plant 
extract and chlorpropamide commenced. 
Animals in group A were orally given 25mg/ml 
of chlorpropamide while the animals in group B 
received 25mg/ml plant extract by oral gavages. 
Animals in group C and D were neither treated 
with chlorpropamide nor plant extracts and 
served as diabetic and non-diabetic controls 
respectively. All the animals were fed ad libitum 
with the normal rat chow and water for the 
period the treatments and experiments lasted. 
 
Collection of blood and serum preparation 
Blood samples were collected from the animals 
anaesthetized with chloroform through cardiac 
puncture using a hypodermic needle and syringe. 
The blood was collected 24hours, 72hours and 
7days after the induction of diabetes. The serum 
was separated by centrifuging approximately 
5ml each of the blood samples with an MSE 
table centrifuge (Minor Gallenkamp) at 4,000×g 
for 10 minutes. The serum obtained was used 
immediately for the estimation of blood glucose, 
total serum protein, serum cholesterol, lipid per 
oxidation and activities of serum glutamic 
pyruvate transaminase (SGPT) and serum 
glutamic oxaloacetate transaminase (SGOT) . 
 
Determination of biochemical parameters 
The concentration of blood glucose was 
determined using the o-toludine method as 
previously described18,19. The serum cholesterol 
was determined using the Ilca’s method as 
previously described19. Lipid per oxidation was 
estimated using the method as previously 
described20. The serum total protein was 
estimated using the Biuret method as previously 
described21 and the SGPT activity was 
determined using the method as previously 
described22 while the SGOT activity was also 
determined using the method as previously 
described22. 
 
Statistical analysis                                                
Data were expressed as mean ± standard error of 
mean. Statistical analyses were done by using 
the student t-test. Significance was checked at 
P0.05 
 
RESULTS 
 
Effects of plant extract and chlorpropamide 
(diabenese) on blood glucose 
The plant extracts and chlorpropamide 
(diabenese) caused a reduction in the blood  
 152
Table 1: Effects of plant extract and chlorpropamide (diabenese) on 
blood glucose  
                                                                          Blood glucose level (mM/L) 
Time 
(Hours/Days) 
Diabenese 
Treated 
Group 
(A) 
Plant extract 
Treated 
Group 
(B) 
Diabetic 
Control 
Group 
(C) 
Non diabetic 
Control 
Group 
(D) 
24 hours 12.35±1.1 10.98±1.6 13.45±2.1             9.02±0.3 
3 days 11.77±3.2 10.40±1.3 13.98±0.5 9.20±0.1 
7 days 10.31±2.1 9.71±0.5 14.75±0.1 9.37±0.6 
 
TABLE 2: Effects of plant extract and chlorpropamide (diabenese) on serum 
cholesterol level  
                                                         Serum cholesterol level (mM/L) 
        Time 
(Hours/Days) 
Diabenese  
Treated 
Group 
      (A) 
Plant extract 
Treated  
Group 
      (B) 
Diabetic 
Control 
Group 
        (C) 
Non diabetic 
Control 
Group 
       (D) 
24 hours 9.40±3.4 8.70±2.7 10.40±1.0 6.80±0.2 
3 days 8.10±0.3 7.60±1.1 11.90±2.1 6.89±1.7 
7 days 7.90±1.6 7.00±1.6 12.06±0.8 6.98±1.7 
 
glucose concentration of the rats. The plant 
extract reduced the concentration of glucose 
from 13.45±2.1 to10.98±1.6mM/L while 
chlorpropamide reduced it to 12.35±1.1mM/L 
after 24hours as shown in Table 1. Similar 
reductions in blood glucose were observed after 
3 and 7 days. The results show that the plant 
extracts reduced blood glucose more than the 
chlorpropamide. These reductions were 
significant (P0.05). 
 
Effects of plant extract and chlorpropamide 
(diabenese) on serum cholesterol 
Table 2 shows that both chlorpropamide 
(diabenese) and the plant extracts caused 
significant (P0.05) reductions in serum 
cholesterol from 10.40±1.0mM/L to 
9.40±3.4mM/L and 8.70 ±2.7mM/L respectively 
after 24 hours. A higher reduction in serum 
cholesterol was observed for both diabenese and 
the plant extracts after 3 and 7 days. The plant 
extracts caused more reductions in the serum 
cholesterol when compared to diabenese. 
 
Effects of plant extract and chlorpropamide 
(diabenese) on serum protein 
The total serum protein was also reduced by 
both chlorpropamide (diabenese) and the plant 
extracts with the plant extracts causing higher 
reductions when compared to diabenese as 
shown in Table 3. 
 
 
Table 3: Effects of plant extract and chlorpropamide (diabenese) on total 
serum protein concentration  
                                                                 Serum protein concentration (mg/ml) 
        Time 
(Hours/Days) 
Diabinese  
Treated 
Group 
       (A) 
Plant extract 
Treated  
Group 
      (B) 
Diabetic 
Control 
Group 
        (C) 
Non diabetic 
Control 
Group 
       (D) 
24 hours 17.40±7.1 16.00±6.2 18.10±1.0 10.00±1.2 
3 days 17.60±4.7 14.80±9.1 18.98±3.6 10.40±6.1 
7 days 14.01±1.1 13.60±1.6 19.59±7.1 10.48±1.9 
 
 153
Effects of plant extracts and chlorpropamide 
(diabenese) on serum lipid peroxidation 
Table 4 shows that both the plant extracts and 
chlorpropamide (diabenese) almost completely 
reduced the level of lipid peroxidation after 7 
days from 13.40 ±1.5mM/L to 1.5± 0.8 mM/L 
and 1.98± 6.2mM/L respectively. Also higher 
reductions in lipid peroxidation were achieved 
with the plant extracts. These values were 
significant at P0.05. 
 
Effects of plant extracts and chlorpropamide 
(diabenese) on serum glutamate pyruvate 
transaminase (SGPT) activity 
The activity of serum glutamate pyruvate 
transaminase (SGPT) was significantly reduced 
(P0.05) after 7 days by both the plant extracts 
and chlorpropamide (diabenese) from 109.10± 
0.8I.U/ml to 37.10± 0.1I.U/ml and 39.80± 
1.7I.U/ml respectively. These values are shown 
in Table 5. 
 
Effects of plant extract and chlorpropamide 
(diabenese) on serum glutamate oxaloacetate 
transaminase (SGOT) activity 
Reductions in the activity of serum glutamate 
oxaloacetate transaminase (SGOT) occurred 
with both the plant extracts and chlorpropamide 
(diabenese) only after 24 hours and 3 days. The 
plant extracts caused more reductions than the 
diabenese especially after 3 days as shown in 
Table 4. These reductions were also significant 
at P0.05. 
 
 
Table 4: Effects of plant extract and chlorpropamide (diabenese) on serum lipid 
peroxidation  
                                                             Serum lipid peroxidation (mM/L) 
        Time 
(Hours/Days) 
Diabinese  
Treated 
Group 
      (A) 
Plant extract 
Treated  
Group 
      (B) 
Diabetic 
Control 
Group 
   (C) 
Non diabetic 
Control 
Group 
       (D) 
24 hours 5.40±3.7 3.60±1.1 7.20±0.7 1.60±2.1 
3 days 4.20±1.8 2.51±0.9 9.81±2.0 1.51±0.5 
7 days 1.98±6.2 1.50±0.8 13.40±1.5 1.45±1.4 
 
Table 5: Effects of plant extract and chlorpropamide (diabenese) on serum 
glutamate pyruvate transaminase (SGPT) activity 
                                                                              SGPT activity (I.U/ml) 
        Time 
(Hours/Days) 
Diabinese  
Treated 
Group 
           (A) 
Plant Extract 
Treated  
Group 
      (B) 
Diabetic 
Control 
Group 
        (C) 
Non Diabetic 
Control 
Group 
       (D) 
24 hours 92.60±5.6 80.10±2.2 99.10±1.2 34.16±6.7 
3 days 72.10±3.0 55.22±1.7 106.20±3.1 33.08±0.2 
7 days 39.80±1.7 37.10±0.1 109.10±0.8 32.10±1.7 
 
Table 6: Effects of plant extract and chlorpropamide (diabenese) on serum 
glutamate oxaloacetate transaminase (SGOT) activity 
                                                                             SGOT activity (I.U/ml) 
        Time 
(Hours/Days) 
Diabenese  
Treated 
Group 
      (A) 
Plant Extract 
Treated  
Group 
      (B) 
Diabetic 
Control 
Group 
     (C) 
Non Diabetic 
Control 
Group 
       (D) 
24 hours 105.10±2.5 100.80±6.0 109.10±1.1 70.10±3.2 
3 days 90.26±0.8 72.17±0.3 118.06±3.6 71.0±1.7 
7 days 73.07±1.2 73.07±1.2 66.12±2.9 71.98±0.6 
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DISCUSSION 
 
Diabetes characterized by deleterious 
hyperglycemia is one of the leading diseases in 
the world23. There is a high level of treatment 
failures and unpleasant side effects associated 
with oral anti-diabetic drugs generating an 
urgent need and desire for alternative 
treatments24. Folklore and the use of plant based 
products are becoming popular in the treatment 
and management of diabetes. Catharanthus 
roseus is used in the treatment of diabetes in 
India. 
 
The effect of the organic extracts of the leaves of 
C. roseus on blood glucose has been studied in 
rats25. This study investigated the effects of the 
aqueous extracts of flowers, leaves and tender 
stems of C.roseus on blood glucose and some 
other associated parameters. In this present 
study, diabetes was successfully induced as seen 
in increase in blood glucose in excess of 
300mg/ml in the rats administered alloxan. This 
is in accordance with the work done by Olajide 
et al26. Oral administration of aqueous extracts 
of C.roseus and diabenese caused a significant 
reduction (P0.05) in the blood glucose 
concentration of the albino rats. Data from other 
results27 tallies with our observations on the 
reduction of blood glucose by the aqueous 
extract of C. roseus. Also the reduction in blood 
glucose by chlorpropamide (diabenese) which 
was not as much as that caused by aqueous 
extract of C.roseus is similar to the result 
obtained by Levine28. Alloxan induces diabetes 
by destroying the beta-cells of the Islets of 
Langerhans in the pancreas leading to reduction 
in synthesis and release of insulin29. 
Sulfonylureas such as chlorpropamide are 
known to produce hypoglycemia by acting on 
the beta-cells and thus increasing secretion of 
insulin.C.roseus acts in a similar fashion in 
alloxan-induced diabetes, but the enhanced 
reduction of blood glucose by aqueous extracts 
of the plant as compared to diabenese could be 
attributed to the action of C.roseus on multiple 
sites on the beta-cells so as to sustain increases 
in synthesis and release of insulin. Also 
enhanced tissue response to glucose cannot be 
ruled out as a possible mechanism of action by 
C. roseus. Further work is needed to substantiate 
this possibility. 
 
Serum cholesterol concentrations following the 
treatments with diabenese and the plant extract 
were found to be decreased significantly 
(P0.05).High cholesterol levels is associated 
with coronary heart disease (CHD) observed in 
diabetic patients. The implication of this is that 
the use of aqueous extracts of C. roseus in the 
treatment of diabetes will also ameliorate the 
occurrence of CHD in addition to reducing 
glucose levels.  
 
Assay of liver enzymes SGOT and SGPT 
indicated a decrease in their activities in both 
chlorpropamide (diabenese) and plant extract 
treated groups, eventhough the reductions were 
more in the C.roseus treated group. Increase in 
these liver enzymes is an indication of liver 
damage30 and so from the results obtained in this 
study, the plant extract of C. roseus and 
diabenese had protective effects on the liver. 
 
Oxidative stress is associated with diseases and 
occurs in alloxan-induced diabetic rats seen as 
an increase in malondialdehyde (MDA), an end 
product of lipid peroxidation31,32.There was far 
more increase in lipid peroxidation in the 
negative control group than in the group treated 
with diabenese and C. roseus extract. This 
shows that both diabenese and C. roseus has 
anti-oxidant activity, an attribute required in the 
treatment of diseases. 
 
There were also decreases in total serum protein 
in the groups treated with C. roseus and 
diabenese which could be attributed to increased 
binding of the drug and plant components to 
serum albumins. 
Generally the significant effects of the aqueous 
extracts of the flowers, leaves and tender stems 
of C. roseus which were higher than those 
produced by chlorpropamide (diabenese) in 
alloxan-induced diabetic rats is attributable to its 
content of some bioactive phytochemicals 
notably alkaloids such as vindoline and 
vindolinenine which are known to reduce sugar 
levels33. Other bioactive alkaloids that could 
contribute to the high anti-diabetic actions of C. 
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roseus include reserpine, a tranquilizer and 
vincristine, an anti-carcinogen. 
 
In conclusion, there was a profound reduction in 
glucose levels and other biochemical parameters 
assayed in the rats treated with aqueous extracts 
of C. roseus compared to those treated with 
chlorpropamide (diabenese) relative to the 
controls. Thus plants such as C. roseus may 
complement the use of such effective 
antidiabetic drugs as chlorpropamide  
(diabenese) in treatment of diabetes and also 
contribute to the development of new 
prescription drugs for treatment of diabetes as 
either biochemical models or templates for drug 
synthesis. 
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